bioAffinity Technologies, Inc. (BIAF)
(Delayed Data from NSDQ)
$0.30 USD
-0.01 (-1.94%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $0.30 0.00 (0.67%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Dividend Yield (TTM)
bioAffinity Technologies, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
BIAF 0.30 -0.01(-1.94%)
Will BIAF be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BIAF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BIAF
The Zacks Analyst Blog Highlights Meta Platforms, ServiceNow, Booking, Vaso and bioAffinity Technologies
Top Research Reports for Meta Platforms, ServiceNow & Booking
BIAF: What are Zacks experts saying now?
Zacks Private Portfolio Services
BIAF Stock Rises Post Q1 Earnings Despite Revenue Decline
The Zacks Analyst Blog Highlights Alphabet, Berkshire Hathaway, Visa and bioAffinity Technologies
Top Stock Reports for Alphabet, Berkshire Hathaway & Visa
Other News for BIAF
BIAF Gains Canadian Patent for Innovative Lung Disease Detection Method | BIAF Stock News
BioAffinity Technologies awarded new Canadian patent for CyPath Lung